227 related articles for article (PubMed ID: 11786386)
1. Role of Smad1 and Smad4 proteins in the induction of p21WAF1,Cip1 during bone morphogenetic protein-induced growth arrest in human breast cancer cells.
Pouliot F; Labrie C
J Endocrinol; 2002 Jan; 172(1):187-98. PubMed ID: 11786386
[TBL] [Abstract][Full Text] [Related]
2. Activation of the p21(CIP1/WAF1) promoter by bone morphogenetic protein-2 in mouse B lineage cells.
Yamato K; Hashimoto S; Imamura T; Uchida H; Okahashi N; Koseki T; Ishisaki A; Kizaki M; Miyazono K; Ikeda Y; Nishihara T
Oncogene; 2001 Jul; 20(32):4383-92. PubMed ID: 11466619
[TBL] [Abstract][Full Text] [Related]
3. Smad pathway-specific transcriptional regulation of the cell cycle inhibitor p21(WAF1/Cip1).
Pardali K; Kowanetz M; Heldin CH; Moustakas A
J Cell Physiol; 2005 Jul; 204(1):260-72. PubMed ID: 15690394
[TBL] [Abstract][Full Text] [Related]
4. Bone morphogenetic protein 2 exerts diverse effects on cell growth in vitro and is expressed in human pancreatic cancer in vivo.
Kleeff J; Maruyama H; Ishiwata T; Sawhney H; Friess H; Büchler MW; Korc M
Gastroenterology; 1999 May; 116(5):1202-16. PubMed ID: 10220513
[TBL] [Abstract][Full Text] [Related]
5. Bone morphogenetic protein-2 (BMP-2) transactivates Dlx3 through Smad1 and Smad4: alternative mode for Dlx3 induction in mouse keratinocytes.
Park GT; Morasso MI
Nucleic Acids Res; 2002 Jan; 30(2):515-22. PubMed ID: 11788714
[TBL] [Abstract][Full Text] [Related]
6. Nuclear factor YY1 inhibits transforming growth factor beta- and bone morphogenetic protein-induced cell differentiation.
Kurisaki K; Kurisaki A; Valcourt U; Terentiev AA; Pardali K; Ten Dijke P; Heldin CH; Ericsson J; Moustakas A
Mol Cell Biol; 2003 Jul; 23(13):4494-510. PubMed ID: 12808092
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor beta signaling through Smad1 in human breast cancer cells.
Liu X; Yue J; Frey RS; Zhu Q; Mulder KM
Cancer Res; 1998 Oct; 58(20):4752-7. PubMed ID: 9788633
[TBL] [Abstract][Full Text] [Related]
8. A novel link between the proteasome pathway and the signal transduction pathway of the bone morphogenetic proteins (BMPs).
Lin Y; Martin J; Gruendler C; Farley J; Meng X; Li BY; Lechleider R; Huff C; Kim RH; Grasser WA; Paralkar V; Wang T
BMC Cell Biol; 2002 Jun; 3():15. PubMed ID: 12097147
[TBL] [Abstract][Full Text] [Related]
9. Identification of a BMP-responsive element in Id1, the gene for inhibition of myogenesis.
Katagiri T; Imada M; Yanai T; Suda T; Takahashi N; Kamijo R
Genes Cells; 2002 Sep; 7(9):949-60. PubMed ID: 12296825
[TBL] [Abstract][Full Text] [Related]
10. Activation of the bone morphogenetic protein signaling pathway induces inhibin beta(B)-subunit mRNA and secreted inhibin B levels in cultured human granulosa-luteal cells.
Jaatinen R; Bondestam J; Raivio T; Hildén K; Dunkel L; Groome N; Ritvos O
J Clin Endocrinol Metab; 2002 Mar; 87(3):1254-61. PubMed ID: 11889196
[TBL] [Abstract][Full Text] [Related]
11. Bone morphogenetic protein signaling in prostate cancer cell lines.
Brubaker KD; Corey E; Brown LG; Vessella RL
J Cell Biochem; 2004 Jan; 91(1):151-60. PubMed ID: 14689587
[TBL] [Abstract][Full Text] [Related]
12. The tumor suppressor Smad4/DPC 4 as a central mediator of Smad function.
Zhang Y; Musci T; Derynck R
Curr Biol; 1997 Apr; 7(4):270-6. PubMed ID: 9094310
[TBL] [Abstract][Full Text] [Related]
13. Ubc9 promotes the stability of Smad4 and the nuclear accumulation of Smad1 in osteoblast-like Saos-2 cells.
Shimada K; Suzuki N; Ono Y; Tanaka K; Maeno M; Ito K
Bone; 2008 May; 42(5):886-93. PubMed ID: 18321803
[TBL] [Abstract][Full Text] [Related]
14. Focal adhesion kinase activity is required for bone morphogenetic protein--Smad1 signaling and osteoblastic differentiation in murine MC3T3-E1 cells.
Tamura Y; Takeuchi Y; Suzawa M; Fukumoto S; Kato M; Miyazono K; Fujita T
J Bone Miner Res; 2001 Oct; 16(10):1772-9. PubMed ID: 11585340
[TBL] [Abstract][Full Text] [Related]
15. Characterization of a bone morphogenetic protein-responsive Smad-binding element.
Kusanagi K; Inoue H; Ishidou Y; Mishima HK; Kawabata M; Miyazono K
Mol Biol Cell; 2000 Feb; 11(2):555-65. PubMed ID: 10679014
[TBL] [Abstract][Full Text] [Related]
16. Role of Smad proteins and transcription factor Sp1 in p21(Waf1/Cip1) regulation by transforming growth factor-beta.
Pardali K; Kurisaki A; Morén A; ten Dijke P; Kardassis D; Moustakas A
J Biol Chem; 2000 Sep; 275(38):29244-56. PubMed ID: 10878024
[TBL] [Abstract][Full Text] [Related]
17. BMP-induced growth suppression in colon cancer cells is mediated by p21WAF1 stabilization and modulated by RAS/ERK.
Beck SE; Jung BH; Del Rosario E; Gomez J; Carethers JM
Cell Signal; 2007 Jul; 19(7):1465-72. PubMed ID: 17317101
[TBL] [Abstract][Full Text] [Related]
18. Bone morphogenetic protein 2 is expressed by, and acts upon, mature epithelial cells in the colon.
Hardwick JC; Van Den Brink GR; Bleuming SA; Ballester I; Van Den Brande JM; Keller JJ; Offerhaus GJ; Van Deventer SJ; Peppelenbosch MP
Gastroenterology; 2004 Jan; 126(1):111-21. PubMed ID: 14699493
[TBL] [Abstract][Full Text] [Related]
19. Smad1 and smad5 act downstream of intracellular signalings of BMP-2 that inhibits myogenic differentiation and induces osteoblast differentiation in C2C12 myoblasts.
Yamamoto N; Akiyama S; Katagiri T; Namiki M; Kurokawa T; Suda T
Biochem Biophys Res Commun; 1997 Sep; 238(2):574-80. PubMed ID: 9299554
[TBL] [Abstract][Full Text] [Related]
20. Bone morphogenetic protein-2 induces cyclin kinase inhibitor p21 and hypophosphorylation of retinoblastoma protein in estradiol-treated MCF-7 human breast cancer cells.
Ghosh-Choudhury N; Ghosh-Choudhury G; Celeste A; Ghosh PM; Moyer M; Abboud SL; Kreisberg J
Biochim Biophys Acta; 2000 Jul; 1497(2):186-96. PubMed ID: 10903423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]